ATE542525T1 - Verbesserte pharmazeutische zusammensetzung mit einem pyrrolidon-antikonvulsivum und verfahren zu seiner herstellung - Google Patents

Verbesserte pharmazeutische zusammensetzung mit einem pyrrolidon-antikonvulsivum und verfahren zu seiner herstellung

Info

Publication number
ATE542525T1
ATE542525T1 AT07819022T AT07819022T ATE542525T1 AT E542525 T1 ATE542525 T1 AT E542525T1 AT 07819022 T AT07819022 T AT 07819022T AT 07819022 T AT07819022 T AT 07819022T AT E542525 T1 ATE542525 T1 AT E542525T1
Authority
AT
Austria
Prior art keywords
production
pharmaceutical composition
improved pharmaceutical
pyrrolidone
pyrrolidone anticonvulsant
Prior art date
Application number
AT07819022T
Other languages
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Dimitrios Bikiaris
Vicky Samara
Ioanna Koutri
Eleni Stathaki
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Application granted granted Critical
Publication of ATE542525T1 publication Critical patent/ATE542525T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT07819022T 2007-10-16 2007-10-16 Verbesserte pharmazeutische zusammensetzung mit einem pyrrolidon-antikonvulsivum und verfahren zu seiner herstellung ATE542525T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/008952 WO2009049642A1 (en) 2007-10-16 2007-10-16 Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE542525T1 true ATE542525T1 (de) 2012-02-15

Family

ID=39494325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07819022T ATE542525T1 (de) 2007-10-16 2007-10-16 Verbesserte pharmazeutische zusammensetzung mit einem pyrrolidon-antikonvulsivum und verfahren zu seiner herstellung

Country Status (10)

Country Link
US (1) US8187635B2 (de)
EP (1) EP2197428B1 (de)
AT (1) ATE542525T1 (de)
CA (1) CA2696977C (de)
CY (1) CY1112702T1 (de)
DK (1) DK2197428T3 (de)
ES (1) ES2380010T3 (de)
PL (1) PL2197428T3 (de)
WO (1) WO2009049642A1 (de)
ZA (1) ZA201003380B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102666512B (zh) 2009-10-13 2014-11-26 奥斯特姆医疗公司 对疾病治疗有用的mek抑制剂
US9333175B2 (en) * 2010-06-16 2016-05-10 Mylan Inc. Controlled release levetiracetam formulations and methods for producing the same
US8912215B2 (en) 2011-12-13 2014-12-16 Everon Biosciences, Inc. Rapamycin composition
CA2906029C (en) 2013-03-15 2017-09-05 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
JP6422464B2 (ja) * 2016-05-19 2018-11-14 エルメッド エーザイ株式会社 レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤
BR112022001968A2 (pt) * 2019-08-06 2022-05-10 Justin Kirkland Formulações que incluem di-hidrohonokiol
CN114917195B (zh) * 2022-06-13 2024-06-11 河北戴桥医药科技有限公司 一种吡拉西坦片剂及其制备方法
CN115869280A (zh) * 2022-11-15 2023-03-31 澳美制药(海南)有限公司 左乙拉西坦片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329217B2 (en) * 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
CN1720025A (zh) * 2002-10-08 2006-01-11 兰贝克赛实验室有限公司 加巴喷丁片剂及其制备
CN1802352A (zh) * 2003-02-03 2006-07-12 特瓦制药工业有限公司 制备左乙拉西坦的方法
WO2006070406A1 (en) 2004-12-29 2006-07-06 J.B. Chemicals & Pharmaceuticals Ltd Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
WO2006102750A1 (en) 2005-03-30 2006-10-05 Genpharm Inc. Combined-step process for pharmaceutical compositions
NL2000281C2 (nl) * 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
EP1810676B1 (de) 2006-01-24 2008-11-12 Teva Pharmaceutical Industries Limited Zusammensetzungen enthaltend Levetiracetam und Verfahren zu deren Herstellung.

Also Published As

Publication number Publication date
CA2696977C (en) 2012-12-04
WO2009049642A1 (en) 2009-04-23
ZA201003380B (en) 2011-12-28
US8187635B2 (en) 2012-05-29
DK2197428T3 (da) 2012-04-02
CY1112702T1 (el) 2016-02-10
EP2197428B1 (de) 2012-01-25
EP2197428A1 (de) 2010-06-23
US20110033538A1 (en) 2011-02-10
PL2197428T3 (pl) 2012-06-29
ES2380010T3 (es) 2012-05-07
CA2696977A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
ATE542525T1 (de) Verbesserte pharmazeutische zusammensetzung mit einem pyrrolidon-antikonvulsivum und verfahren zu seiner herstellung
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
MY142029A (en) Phenoxyacetic acid derivatives
EA201100691A1 (ru) Антагонисты рецепторов лизофосфатидной кислоты
HRP20150375T1 (hr) Derivati piridazinona
TW200612892A (en) Novel compounds
MY142046A (en) Rapid dissolution formulation of a calcium receptor-active compound
ATE513820T1 (de) Neue benzamidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung, die diese enthält
WO2010097243A3 (en) Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts
TNSN07435A1 (en) Novel piperidine carboxylic acid amide derivatives
WO2011023367A3 (en) Bisphosphonate-prodrugs
WO2010067987A2 (ko) 신규한 2, 6-위치에 치환된 3-니트로피리딘 유도체, 그의 제조방법 및 이를 포함하는 약학 조성물
HRP20120867T1 (hr) Selurampanel
WO2009145590A3 (en) Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
WO2009049648A3 (en) Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
ATE425961T1 (de) Salze substituierter allophansaureester und deren verwendung in arzneimitteln
EA201170583A1 (ru) Новая композиция для лечения эссенциальной тромбоцитемии
WO2010033981A3 (en) 5-azaindole bisphosphonates
WO2007109615A3 (en) β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії
ATE419838T1 (de) Pharmazeutische zubereitungsform von aliphatischen amin-polymeren und verfahren zu deren herstellung
EA200701688A1 (ru) Замещённые пирролы, содержащие их композиции, способ получения и применение
MX2012001298A (es) Acido r-7-(3-aminometil-4-metoxiimino-3-metil-pirrolidin-1-il)-1-c iclopropil-6-fluoro-4-oxo-1,4-dihidro-[1,8]naftiridin-3-carboxili co y sal de acido l-aspartico, proceso para la preparacion de los mismos y composicion farmaceutica que comprende los mismos para antimicrobiano.
CY1108846T1 (el) Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της